Sinopeg

SINOPEG is a dynamic science company dedicated to drug delivery systems (DDS). As a leading company in polyethylene glycol derivatives (PEGs), they are also specialized in the R&D of long acting biopharmaceuticals, developing and manufacturing of block copolymers, lipids for drug delivery, medical devices, bio-engineering, and other broad uses.

With proprietary technologies and state-of-the-art GMP standard manufacturing capability, SINOPEG is capable of supplying small to large quantities of rich selection of PEG derivative products with unique molecular designs (chemical structure, molecular weights (MW)) and exceptional product quality control to serve bio-technology and pharmaceutical companies and research organizations worldwide.

SINOPEG is a proud collaborator with a number of well-known universities, research institutes, and pharmaceutical and biotech companies around the globe.
 
SINOPEG’s Advantages:
   •   SINOPEG has 24+ patents on PEG Derivatives and Pegylated Drugs.
   •   ISO-9001and ISO-13485 certified.
   •   Multiple Drugs Master File（DMF）submissions.

Certificate Of Analysis (COA)
COAs will be provided for all products ordered from SINOPEG.

Special Customization
SINOPEG is able to customize a wide range of PEG products from mg to kg, and our products can meet the specific requirements of customers.

The prices are on request! Contact Us by e-mail info@sobekbio.com

Sanyou Biopharmaceuticals

Sanyou Biopharmaceuticals is a global leader in high-tech biotechnology, specializing in innovative biologics R&Dand services. Sanyou integrated 4C model - "differentiated CRO, integrated CDO, innovative CPO and characteristic CRS” bridges research and manufacturing, simplifying the discovery of groundbreaking biologics worldwide.

Sanyou has nearly 300 skilled professionals in drug development and industrialization. They have a fully equipped 20,000 square meters integrated lab and three industry-leading innovative technology platforms - “super-trillion, integration, and intelligence", and can offer customizable service to support client needs. Sanyou is committed to refining their proprietary platform and introducing upgraded services and technologies. With over 1000 global collaborations, Sanyou continues to actively collaborate with pharmaceutical companies, drug R&D institutions and diagnostics companies, cultivating a collaborative growth ecosystem and a thriving community with clients and partners.
www.sanyoubio.com / crs.sanyoubio.com

The prices are on request! Contact Us by e-mail info@sobekbio.com

Anti-CXCL8 / IL-8 Reference Antibody (Genentech patent anti-IL-8) CHA784

The add to cart button will appear once you select the values above

Specifications

size	50 μg / 100 μg / 1 mg

Description:

Anti-CXCL8 / IL-8 Reference Antibody (Genentech patent anti-IL-8)(CHA784) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Product type:

Antibody

Host:

CHO

Target name:

CXCL8 / IL-8

Target species:

Human

Isotype:

IgG

Buffer:

100 mM Pro-Ac 20 mM Arg pH5.0

Applications:

ELISA、FACS、Kinetics (BLI)、Kinetics (SPR)、Functional assay

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com